Topics:

M.D. Anderson and AstraZeneca form neuropathic pain alliance

M.D. Anderson and AstraZeneca form neuropathic pain alliance

HOUSTON—M.D. Anderson Cancer Center and AstraZeneca will collaborate to help advance the understanding of neuropathic pain caused by cancer chemotherapy. The alliance will focus on identifying neurobiological differences between cancer patients who develop such pain and those who do not, and better understanding the mechanisms through which chemotherapies cause peripheral nerve dysfunctions.

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.